Article
AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition.
Journal of translational medicine - 6 Jul 2026
Bakhshian Atefeh, Ghorghanlu Sajjad, Atanaki Fereshteh Fallah, Ezadyar Elham Erfani, Ashkiyan Azadeh, Etemadi Ali, Negahdari Babak, Kavousi Kaveh, Kardar Gholamali, Mazloomi Mohammadali
Abstract excerpt
BACKGROUND: Neoantigens-tumor-specific peptides generated by somatic mutations-are central targets of effective anticancer T cell immunity and underpin the clinical success of immune checkpoint blockade and personalized cancer vaccines. Advances in high-throughput sequencing, immunopeptidomics, and artificial intelligence (AI) have transformed neoantigen discovery from tailored experimental workflows into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
